跳至主要内容
临床试验/NCT03565601
NCT03565601Unknown不适用

Phenotypic Features and Prognostic Value of Anti-Ro52 (TRIM-21) Antibodies in Connective Tissue Diseases

Central Hospital, Nancy, France2 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2019年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
400
试验地点
2
主要终点
ILD prevalence

研究概览

简要总结

Anti-Ro52 autoantibodies can be detected in patients with several autoimmune diseases. Clinical significance of anti-Ro52 is controversial. The presence of anti-Ro52 may be a factor associated with disease severity (interstitial lung disease, vasculopathy) and cancers. The aim of this study is to assess interstitial lung disease and vasculopathy prevalence and severity, cancers occurence and others clinical features of connective tissue disease patients with anti-Ro52 autoantibodies.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Connective tissue disease (differenciated or not)
  • Presence of anti-Ro52 antibodies at diagnosis

排除标准

  • Healthy subjects

结局指标

主要结局

ILD prevalence

时间窗: baseline (J0)

Clinical (cough, dyspnea) and/or radiological (tomodensitometry) data

次要结局

  • Vasculopathy occurence(baseline (J0) and follow-up)
  • Cancer occurence(baseline (J0) and follow-up)
  • ILD severity(baseline (J0))

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验